
|Articles|January 15, 2003
Study evaluates role of steroids, system on PME
Sunnyvale, CA-Oculex Pharmaceuticals Inc. has completed patient enrollment in its phase II clinical trial of its lead product, Posurdex, for the treatment of persistent macular edema (PME).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
ICYMI: AAO 2025 showcases new technologies and continued research
3
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
4
Throwback Series: Managing bilateral diabetic macular edema early in practice
5

















































.png)


